Agios Pharmaceuticals, Inc. - Rasio total nilai perusahaan marang pendapatan AGIO

Logo perusahaan publik agios.com (AGIO)

Agios Pharmaceuticals management has pivoted its strategy toward rare genetic pathologies, divesting its oncology business to fund research and development. The GURU.Markets portal displays the EV/Sales multiple, where 7928.50 shows the current value of the metric. Revenues rely on sales of an anemia drug, creating a cash generator. However, high dependence on a narrow portfolio and pricing regulation in the US create certain risks.

AGIO Agios Pharmaceuticals: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Agios - rincian analitis lan metrik utama (AGIO)

Pambiji fundamental perusahaan:AGIO (agios.com)
Produk seri Agios Pharmaceuticals, Inc.

This indicator compares the total enterprise value, adjusted for net debt, against annual sales to determine the asset's market premium. By analyzing the EV/Revenue multiple, an investor can see how the patents of Agios Pharmaceuticals (AGIO) in the field of rare genetic diseases allow the market to value the company with a high multiple premium due to the absence of direct competition.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)